135 mln people move out of poverty in India in 5 years: report

STORY: 135 mln people move out of poverty in India in 5 years: report DATELINE: July 20, 2023 LENGTH: 00:01:39 LOCATION: New Delhi CATEGORY: ECONOMY/SOCIETY SHOTLIST: 1. various of India gate 2. various of gov't buildings 3. various of school-going students 4. various of market 6. various of cooking fuel 7. various of thermal power plant 8. various of traffic STORYLINE: Nearly 135 million people moved out of multidimensional poverty on the yardstick of health, education, and the overall standard of living, over the past five years in India, a report released by the federal government's think-tank NITI Aayog has said. Improvements in nutrition, years of schooling, sanitation, and cooking fuel played a significant role in bringing down poverty across the country, said the report on Monday. This was the second edition of the National Multidimensional Poverty Index (MPI), which represents the country's progress in reducing multidimensional poverty between two surveys, namely the National Family Heath Survey

Myanmar, China jointly produce COVID-19 vaccines

STORY: Myanmar, China jointly produce COVID-19 vaccines DATELINE: March 24, 2022 LENGTH: 00:03:24 LOCATION: YANGON, Myanmar CATEGORY: SOCIETY/HEALTH SHOTLIST: 1. various of the signature ceremony of Myanmar, China cooperation 2. various of the production line of COVID-19 vaccines STORYLINE: Myanmar launched the production of Myancopharm COVID-19 vaccines in Yangon on Wednesday at Myanmar Pharmaceutical Industry (MPI) in collaboration with China. Lt.-Gen. Aung Lin Dwe, secretary of the State Administration Council (SAC), said Myanmar has trialed and produced COVID-19 vaccines domestically in cooperation with Sinopharm CNBG. "Technology for vaccine production was obtained and foreign currency use would be reduced as Myancopharm COVID-19 vaccines were successfully produced in the country," he said. Chinese Ambassador Chen Hai said Sinopharm's cooperative Ready to Fill (RTF) Bulk vaccine plant with Myanmar is the Chinese pharmaceutical company's first COVID-19 vaccine plant officially put into operation in